News | News By Subject | News by Disease News By Date | Search News

Herpes genital (genital Herpes simplex) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Genocea (GNCA) Stock Doubles After Market Yesterday on Positive 12 Months Genital Herpes Data     4/1/2016
Genocea Biosciences (GNCA)'s GEN-003 Meets Primary Endpoint In Phase II Genital Herpes Trial     10/7/2015
Three Cancer Drugs are Up for FDA Approval in October     9/28/2015
Vical  (VICL) Herpes Vaccine Clinical Trial Disappoints with "Confounding Results"     6/24/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
GlaxoSmithKline (GSK)'s Herpes Vaccine Fails in Trial, US National Institutes of Health (NIH) Says     9/30/2010
BioAlliance Pharma Announces Positive Preliminary Pivotal Phase III Results in Herpes Labialis with Acyclovir Lauriad(R)     8/26/2009
Starpharma Holdings Ltd Reports Positive VivaGel(R) Clinical Study Results     5/12/2008
Sciele Pharma, Inc. (SCRX) Signs Exclusive Zovirax(R) Promotional Agreement With Biovail Corporation (BVF)     12/20/2006
Renovis, Inc. (RNVS) Drug Fails Mid-Stage Trial     3/8/2005
Flamel Technologies (FLML) Announces Termination Of Licensing Agreement With Biovail Laboratories Inc. For Genvir And Recovery Of Rights     3/4/2005
PRO 2000, Under Development By Indevus Pharmaceuticals, Inc., (IDEV) Shown To Inhibit HIV And Herpes Simplex Virus Infection Following Human Administration     2/25/2005
Antigenics Inc. (AGEN) Sells Feline Leukemia Vaccine Manufacturing Business To Virbac S.A. (FR:PVIRP) For $14.25 Million In Cash     3/18/2004

News from Around the Web
Constipated? Study Finds Surprising Cause, Yale University Reveals     6/9/2016
Experimental Vaccine Cures Pre-Cancer Vulvar Growths, Leiden University Medical Center Study     11/5/2009
Herpes Medication Does Not Reduce Risk Of HIV Transmission, University of Washington Study     5/8/2009
Cream 'Could Stop Genital Herpes', Harvard Medical School Study     1/22/2009
Herpes Virus Changes Anti-Herpes Drug to Form that Hinders AIDS Virus, National Institutes of Health (NIH) Study     9/11/2008
Second Study Finds Treating Herpes Won't Stop HIV, London School of Hygiene and Tropical Medicine Study     3/13/2008
Novel Vaccine Concept Developed By Scientists At The Wistar Institute     1/31/2008
Drugs Can Lower Risk of Genital Herpes Recurrence     8/14/2007
New Approach Offers Hope For An Effective Herpes Vaccine     1/22/2007
Study Shows How Herpes Infects Cornea, Evades immune cells     9/25/2006
New Study Shows Herpes Cases Declining     8/23/2006
Experimental Vaginal Gel Inhibits HIV And HSV     1/24/2006
FDA Proposes Easing Rules On Herpes Tests     1/9/2006
One-Day Antiviral Treats Recurrent Genital Herpes     1/3/2006
Long-Lasting Gel Against Herpes     5/2/2005

Press Releases
Flawed Herpes Testing Leads To Many False Positives — And Needless Suffering     1/26/2017
Genocea (GNCA) Announces Positive 6-Month Results From GEN-003 Phase 2b Clinical Trial     1/5/2017
The Center for the Biology of Chronic Disease Release: Genital Herpes - Clinical Study Recommends Gene-Eden-VIR/Novirin As A Natural Alternative To Leading Drugs For Both Severe And Mild Cases: CBCD Reports Publication Of A New Scientific Paper     10/25/2016
Rational Vaccines Release: First Ever Human Trial Of A Live Attenuated Functioning Therapeutic Herpes Vaccine     10/17/2016
Genocea (GNCA)'s Genital Herpes Candidate Successful in Mid-Stage Trial     9/29/2016
Antiviral Dietary Supplement More Effective Than Acyclovir, Valacyclovir, And Famciclovir: CBCD Reports Publication Of A New Clinical Study     9/16/2016
AiCuris Initiates Clinical Development For Topical Pritelivir, A Highly Active Inhibitor For The Treatment Of Herpes Simplex Virus     4/4/2016
NanoViricides, Inc. (NNVC.PK) Signs Agreement For Ocular Testing Of Its Drug Candidates For The Treatment Of Herpes Keratitis With The University of Pittsburgh     2/11/2016
NanoBio Corporation's Genital Herpes Vaccine Demonstrates Efficacy In Guinea Pigs As Both A Prophylactic And A Therapeutic Vaccine     9/23/2015
NanoViricides, Inc. (NNVC.PK) Accelerates Its Herpes Drug Development Program     8/17/2015
NanoViricides, Inc. (NNVC.PK) Discusses The Strong Effectiveness Of Its Anti-Herpes Drug Candidates In A Lethal Animal Model Of Dermal Herpes Infection     4/27/2015
Genocea Biosciences Completes Enrollment Early In Phase 2 Dose Optimization Trial Of GEN-003 For Treatment Of Genital Herpes     1/7/2015
NanoBio CorporationTo Present Data Demonstrating The Potential For Its Intranasal Vaccine To Protect Against Genital Herpes Infection     10/8/2014
Admedus Herpes Interim Phase I Results     2/3/2014
Vical Incorporated (VICL) Announces Initiation Of Phase 1/2 Trial Of A Therapeutic HSV-2 Vaccine For Genital Herpes     12/17/2013